Bringing Specificity to Treatment of Disease

Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and albumin binding technology.

Affibody® molecules are small and robust high affinity protein molecules that can be engineered to bind specifically to a large number of target proteins. The company also offers access to its proprietary albumin binding technology for extended plasma half life of protein and peptide based drugs.

 
View an animation of how Affibody® molecules will enable cancer specialists to locate and treat tumors and metastases!